Scientists are calling a new drug called donanemab a "turning point" in the fight against Alzheimer's, the BBC reports, with a major trial showing a significant slowing down in cognitive decline. Regulatory bodies in the UK are now considering whether the drug could be used by the country's National Health Service. As detailed in a […]